E-LIB Suche - Ergebnisse für: Narhi, Linda O.

1

Evaluating Clinical Safety and Analytical Impact of Subvisi..:

Saggu, Miguel ; Bou-Assaf, George M. ; Bucher, Reinhard...
Journal of Pharmaceutical Sciences. 113 (2024) 5 - p. 1401-1414 , 2024

Link: https://doi.org/10.1016/..

2

A High Threshold of Biotherapeutic Aggregate Numbers is Nee..:

Cohen, Joseph R. ; Brych, Stephen R. ; Prabhu, Siddharth...
Pharmaceutical Research. 41 (2024) 4 - p. 651-672 , 2024

Link: https://doi.org/10.1007/..

3

A Cluster of Articles in Memory of Wim Jiskoot, Ph.D:

Crommelin, Daan J.A. ; Narhi, Linda O. ; Das, Tapan K.
Journal of Pharmaceutical Sciences. 111 (2022) 4 - p. 859-860 , 2022

Link: https://doi.org/10.1016/..

4

Stress Factors in Protein Drug Product Manufacturing and Th..:

Das, Tapan K. ; Sreedhara, Alavattam ; Colandene, James D....
Journal of Pharmaceutical Sciences. 111 (2022) 4 - p. 868-886 , 2022

Link: https://doi.org/10.1016/..

5

Stress Factors in Primary Packaging, Transportation and Han..:

Narhi, Linda O. ; Chou, Danny K. ; Christian, Twinkle. R....
Journal of Pharmaceutical Sciences. 111 (2022) 4 - p. 887-902 , 2022

Link: https://doi.org/10.1016/..

6

Silicone Oil Particles in Prefilled Syringes With Human Mon..:

Joh, Nathan H. ; Thomas, Lisa ; Christian, Twinkle R....
Journal of Pharmaceutical Sciences. 109 (2020) 1 - p. 845-853 , 2020

Link: https://doi.org/10.1016/..

7

Stress Factors in mAb Drug Substance Production Processes: ..:

Das, Tapan K. ; Narhi, Linda O. ; Sreedhara, Alavattam...
Journal of Pharmaceutical Sciences. 109 (2020) 1 - p. 116-133 , 2020

Link: https://doi.org/10.1016/..

8

Characterization of Subvisible Particles in Biotherapeutic ..:

Jiao, Nancy ; Barnett, Gregory V. ; Christian, Twinkle R....
Journal of Pharmaceutical Sciences. 109 (2020) 1 - p. 640-645 , 2020

Link: https://doi.org/10.1016/..

9

Chemical and Biophysical Characteristics of Monoclonal Anti..:

Narhi, Linda O. ; Luo, Quanzhou ; Wypych, Jette...
Pharmaceutical Research. 34 (2017) 12 - p. 2817-2828 , 2017

Link: https://doi.org/10.1007/..

10

Mouse Models for Assessing Protein Immunogenicity: Lessons ..:

Jiskoot, Wim ; Kijanka, Grzegorz ; Randolph, Theodore W....
Journal of Pharmaceutical Sciences. 105 (2016) 5 - p. 1567-1575 , 2016

Link: https://doi.org/10.1016/..

11

Immunogenicity of Therapeutic Protein Aggregates:

Moussa, Ehab M. ; Panchal, Jainik P. ; Moorthy, Balakrishnan S....
Journal of Pharmaceutical Sciences. 105 (2016) 2 - p. 417-430 , 2016

Link: https://doi.org/10.1016/..

12

Use of In Vitro Assays to Assess Immunogenicity Risk of Ant..:

Joubert, Marisa K. ; Deshpande, Meghana ; Yang, Jane...
PLOS ONE. 11 (2016) 8 - p. e0159328 , 2016

Link: https://doi.org/10.1371/..

13

Subvisible (2–100 μm) particle analysis during biotherapeut..:

Corvari, Vincent ; Narhi, Linda O. ; Spitznagel, Thomas M....
Biologicals. 43 (2015) 6 - p. 457-473 , 2015

Link: https://doi.org/10.1016/..

14

Physical Characterization and In Vitro Biological Impact of..:

Telikepalli, Srivalli ; Shinogle, Heather E. ; Thapa, Prem S....
Journal of Pharmaceutical Sciences. 104 (2015) 5 - p. 1575-1591 , 2015

Link: https://doi.org/10.1002/..

15

Subvisible (2-100 μm) Particle Analysis During Biotherapeut..:

Narhi, Linda O. ; Corvari, Vincent ; Ripple, Dean C....
Journal of Pharmaceutical Sciences. 104 (2015) 6 - p. 1899-1908 , 2015

Link: https://doi.org/10.1002/..